A product related to multiple sclerosis treatment earns FDA approval.
The U.S. Food and Drug Administration has approved a supplemental biologics license application for two Bayer products that help multiple sclerosis patients keep track of their injections of Betaseron (interferon beta-1b).
The products are the myBETAapp and the Betaconnect Navigator software. A biologics license application is a request for permission to market a biologic product.
Read full article: MS Injection-tracking Products from Bayer Receive FDA Approval
|Read Full Article: MS Injection-tracking Products from Bayer Receive FDA Approval|